Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of MVA-NP+M1 influenza vaccine in healthy adults
2009-010334-21Phase 2Terminated
- Sponsor
- University of Oxford
- Start
- Apr 2009
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of VTP-100 in influenza, sponsored by University of Oxford. Primary endpoint: Safety of MVA-NP+M1 vaccination. Started Apr 2009; status: terminated.
02
Drugs
VTP-100
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-010334-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010334-21.